Evidence map›Paper›PMID 16118414›Full record

ArticleMolecular biotechnology2005

Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.

Yongjun Jiao, Ping Zhao, Jin Zhu, Tessa Grabinski, Zhengqing Feng, Xiaohong Guan, R Scot Skinner, Milton D Gross, Rick V Hay, Hiroshi Tachibana and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Targeting c-Met on gastric cancer cells through a fully human fab antibody isolated from a large naive phage antibody library.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Yongjun JiaoAntibody Technology Laboratory, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Ping Zhao
Jin Zhu
Tessa Grabinski
Zhengqing Feng
Xiaohong Guan
R Scot Skinner
Milton D Gross
Rick V Hay
Hiroshi Tachibana
Brian Cao
Van Andel Institute · USNanjing Medical University · CNVA Ann Arbor Healthcare System · USTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inappropriate expression of the receptor tyrosine kinase Met and its ligand hepatocyte growth factor (HGF)/scatter factor (SF) is usually associated with an aggressive solid tumor phenotype (angiogenesis, invasiveness, and metastasis) and poor clinical prognosis. We report here the design and construction of a large, human naïve antigen-binding fragment (Fab) phage-display library with a diversity of 2.0 x 109, which allows rapid isolation of antigen-specific human antibody fragments. A Fab fragment specifically against Met (designated hFab-Met-1) was successively selected from this library by using biopanning on Met-transfected cell line S114. The specificity of hFab-Met-1 was characterized by immunoprecipitation, Western blotting, and flow cytometry. The results demonstrate that hFab-Met-1 reacts with the extracellular domain of Met in its native conformation. Moreover, functional analysis by Madine-Darby canine kidney cell scattering and urokinase-type plasminogen activator assays demonstrated that hFab-Met-1 is not an agonist to HGF/Met signaling compared with a murine intact monoclonal antibody (MAb) Met5. To confirm that hFab-Met-1 interacts with Met-expressing tumors in vivo, I-125-labeled hFab-Met-1 was nuclear-imaged in a mouse xenograft of Met- and HGF/SF-expressing human leiomyosarcoma. Total body scintigrams were obtained between 1 and 48 h postinjection (PI). Tumor-associated activity was imaged as early as 1 h PI, and remained visible in some animals as late as 24 h PI. As expected, activity was highest in the kidneys in early images, whereas thyroid activity became predominant in later images. In conclusion, hFab-Met-1 interacts with Met both in vitro and in vivo, and is a promising candidate for clinical diagnosis and therapeutics.

Indexed as

Antibodies, MonoclonalPeptide LibraryAnimalsAntineoplastic AgentsBlotting, WesternElectrophoresis, Polyacrylamide GelHepatocyte Growth FactorHumansImmunoglobulin Fab FragmentsImmunoprecipitationLeiomyosarcomaNeoplasm InvasivenessPolymerase Chain ReactionProto-Oncogene Proteins c-metRadioimmunodetectionRadiopharmaceuticalsAntibodies, MonoclonalAntineoplastic AgentsHepatocyte Growth FactorImmunoglobulin Fab FragmentsPeptide LibraryProto-Oncogene Proteins c-metRadiopharmaceuticals

Identifiers

PMID16118414
OpenAlexW1966650950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.